Premium
QIP on baseline prolactin monitoring in psychiatric inpatients on antipsychotics
Author(s) -
Ali Shaazneen,
Thomas Emily Simon,
Looby Saran,
Beveridge Ed
Publication year - 2015
Publication title -
progress in neurology and psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.19
H-Index - 12
eISSN - 1931-227X
pISSN - 1367-7543
DOI - 10.1002/pnp.397
Subject(s) - hyperprolactinaemia , mental health , psychiatry , context (archaeology) , baseline (sea) , medicine , physical health , prolactin , paleontology , oceanography , hormone , biology , geology
Mental health patients suffer higher rates of mortality and morbidity due to physical health problems. A number of antipsychotics are associated with significant increases in plasma prolactin levels and the risk of hyperprolactinaemia. The importance of physical health monitoring is increasingly recognised and commissioned for in mental health services. In the context of greater focus on physical health monitoring in mental health settings, this project set out to assess and improve compliance with guidance on baseline prolactin level testing of inpatients on antipsychotics.